Orlistat for high triglycerides in people with rare genetic lipid conditions
Treatments studied
Part of Hormones & metabolism clinical trials.
This Phase 2 trial studies how well and how safely orlistat works over the long term for people who have very high triglycerides linked to rare genetic lipid disorders. It may help lower triglycerides and assess long-term side effects, but you must meet specific genetic, lab, and health requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 8 or older
- Have type 1 hyperlipoproteinemia confirmed by genetic testing (or, if not genetically confirmed, still meet the triglyceride level requirement)
- At the end of an 8-week “run-in” period, have fasting triglycerides of at least 750 mg/dL
- If you have diabetes, it must be well controlled (A1c under 8%)
- Agree to avoid orlistat for 2 months before starting, and use pregnancy prevention if you can become pregnant (or prevent pregnancy if you’re a male partner)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 trial tests the safety of a gene therapy for people with inherited, hard-to-control high triglycerides (fat in the blood) who have had pancreatitis episodes. It may help by targeting the genes involved in triglyceride control, but the main goal here is to check safety and tolerability.
This study tests an oral medicine (HRS-5346) to lower lipoprotein(a), a type of fat in the blood linked to heart problems. It might help people with high levels who are at increased risk for heart attacks or strokes.
This trial tests an investigational medication, MAR001, to see if it can lower high levels of fats in the blood (triglycerides and remnant cholesterol) linked to heart disease. If you have these conditions, this treatment might help reduce your risk.
This study tests an experimental drug called DR10624 compared to a placebo in people with severely high triglycerides (fats in the blood). It aims to see if the drug can safely lower these fats and reduce the risk of related health problems like pancreatitis.
This trial tests a new medication, SHR-1918, to lower high triglyceride levels. It may be an option for people with moderately elevated triglycerides and controlled cholesterol.
This trial tests a new medication (QLC7401) for people with high cholesterol that is not well controlled by their current treatment. It aims to see if the drug can help lower LDL-C (bad cholesterol) levels and reduce the risk of heart problems.
Hear when a new Type 1 Hyperlipoprotenemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.